"Altasciences is an internationally recognized contract research organization specializing in Phase I/II clinical trials."

During the past decade, Altasciences Clinical Kansas, Inc. conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 3 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 3 clinical trials were completed. i.e. 17.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Altasciences Clinical Kansas, Inc." #1 sponsor was "Astellas Pharma Global Development, Inc." with 2 trials, followed by "British American Tobacco (Investments) Limited" with 2 trials sponsored, "Cheerain HK Limited" with 2 trials sponsored, "Camino Pharma, LLC" with 1 trials sponsored and "Celldex Therapeutics" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altasciences Clinical Kansas, Inc." #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 3 trials as a collaborator, "Janssen Pharmaceuticals" with 1 trials as a collaborator, "Oneness Biotech Co., Ltd." with 1 trials as a collaborator, "Sanford Burnham Prebys Medical Discovery Institute" with 1 trials as a collaborator and "University of California, San Diego" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Altasciences Clinical Kansas, Inc." are "Healthy" (4 trials), "Healthy Subjects" (3 trials), "Electronic Cigarette Use" (2 trials), "Opioid Use Disorder" (2 trials) and "Tobacco Smoking" (2 trials). Many other conditions were trialed in "Altasciences Clinical Kansas, Inc." in a lesser frequency.

Most popular intervention types in "Altasciences Clinical Kansas, Inc." are "Drug" (14 trials), "Other" (4 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Product A" (2 trials), "Product B" (2 trials), "Product C" (2 trials) and "Product D" (2 trials). Other intervention names were less common.

The vast majority of trials in "Altasciences Clinical Kansas, Inc." are 18 trials for "All" genders.

Currently, there are NaN active trials in "Altasciences Clinical Kansas, Inc.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Altasciences Clinical Kansas, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Altasciences Clinical Kansas, Inc., 13 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".